Zhiyuan “Jason” Zheng, PhD

Director, Economics & Healthcare Delivery Research

Zhiyuan Zheng, PhD, Director of Economics & Healthcare Delivery Research, joined the American Cancer Society (ACS) in 2013. His research focuses on estimating the economic burden of cancer among survivors, their families, employers, and insurers at the national, state, or local levels. He uses publicly/privately available survey and claims data to inform cancer survivorship policies. He also conducts studies to investigate cost as a barrier to receipt of optimal cancer care, needed primary care, and the effects of public policies (e.g., the Affordable Care Act) on receipt of care and on the economic burden of cancer among survivors and their families.

Zheng collaborates with other health economists from the National Cancer Institute, the Centers for Disease Control and Prevention, Agency for Health Research and Quality, and Livestrong Foundation on projects designed to improve our understanding of individual, health care provider, and organizational characteristics for receipt or delivery of high-quality cancer care. He also works closely with American Cancer Society Cancer Action Network (ACS CAN) to provide scientific evidence to support ACS’s policies to mitigate the economic burden of cancer and cost-related barriers for optimal cancer care and/or needed primary care among survivors. He serves as the internal society expert in economic burden of cancer and cost as a barrier to cancer care and acts as a spokesperson to the media when needed. 

Zheng received his PhD in Economics from Virginia Tech in 2011. In 2013, he completed a post-doctoral fellowship in the area of comparative effectiveness research at the University of Maryland School of Pharmacy.